Continued innovation and investment is vital to maintaining the U.S.'s leadership in the biopharma sector. Rob and Jackie sit down with Andrew Geall, Chief Development Officer at Replicate Bioscience, and Deborah Barbara, strategic advisor to Primrose Bio, to discuss the development and potential of mRNA as the fourth pillar of pharmaceutical innovation.

Mentioned

Related

 

Rss Apple Podcaster
Podden och tillhörande omslagsbild på den här sidan tillhör Information Technology and Innovation Foundation (ITIF) — The Leading Think Tank for Science and Tech Policy. Innehållet i podden är skapat av Information Technology and Innovation Foundation (ITIF) — The Leading Think Tank for Science and Tech Policy och inte av, eller tillsammans med, Poddtoppen.